Hiperinsulinismo orgánicoestrategia quirúrgica

  1. J. C. Hermoso Torres 1
  2. B. Pérez Cabrera 1
  3. F. Navarro Freire 1
  4. M. L. Delgado Carrasco 1
  5. C. Garde Lecumberri 1
  6. J. L. Tovar Martínez 1
  7. J. M. García Gil 1
  1. 1 Unidad de Cirugía hepatobiliopancreática. Servicio de Cirugía General y de Ap. Digestivo. Hospital Universitario San Cecilio. Granada
Revista:
Cirugía Andaluza

ISSN: 2695-3811 1130-3212

Año de publicación: 2009

Volumen: 20

Número: 1

Páginas: 31-36

Tipo: Artículo

Otras publicaciones en: Cirugía Andaluza

Referencias bibliográficas

  • Sitges-Serra A, Fernández-Cruz L. Tumores endocrinos del páncreas. En: Manual de la Asociación Española de Cirujanos. Ed. Panamericana 2004, pp. 688-95
  • Rothmund M, Angelini L, Brunt ML, Farndon JR, et al. Surgery for benign insulinoma: an international review. World J Surg. 1990; 14: 393-9.
  • Sunamura M, Fukuyama, S. Surgical treatment of insulinomas. En: Beger HG, Matsuno S, Cameron JL (eds). Diseases of the Pancreas. Ed. Springer Berlin Heidelberg 2008; 63: 715-21.
  • Pasieka JL, McLeod MK, Thompson NW, Burney RE. Surgical approach to insulinomas: assesing the need for preoperative localization. Arch Surg 1992; 127: 442-7.
  • Boukhman MP, Karam JM, Shaver J, Siperstein AE, et al. Localization of insulinomas. Arch Surg 1999; 134: 818-23.
  • Ravi K, Britton BJ. Surgical approach to insulinomas: are preoperative localisation tests necessary? Ann R Coll Surg Engl. 2007; 89(3): 212–7.
  • Chen X, Cai WY, Yang WP, Li HW. Pancreatic insulinomas: diagnosis and surgical treatment of 74 patients. Hepatobiliary Pancreat Dis Int 2002; 1(3): 458-61.
  • Tucker ON, Crotty PL, Conlon KC. The management of insulinoma. Br. J Surg 2006; 93: 264-75.
  • Del Olmo Martinez ML, González de Canales P, Arranz Santos ML. Tumores endocrinos del páncreas. MEDICINE 2000; 8,8: 404-14.
  • Schumacher B, Lubke HJ, Frieling, T, Strohmeyer G et al. Prospective study on the detection of insulinomas by endoscopic ultrasonography. Endoscopy 1996; 28: 273–6.
  • Abboud B, Boujaoude J. Occult sporadic insulinoma: localization and surgical strategy. World J Gastroenterol 2008; 14(5): 657-65.
  • Sánchez Pernaute A, Pérez Aguirre ME, Talavera Eguizábal P, Torres García A. Tratamiento quirúrgico de los tumores neuroendocrinos gastroenteropancreáticos. Endocrinol Nutr 2007; 54 (Supl 1): 38-43.
  • Priego P, Sanjuanbenito A, Martinez Molina E, Lobo E, et al. Manejo diagnóstico y terapéutico del insulinoma pancreático. Rev Esp Enferm Dig. 2007; 99(4): 218-22.
  • Ramage JK, Davies AH, Ardill J, Bax N et al. Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours. Gut 2005; 54(suppl 4): iv1-iv16.
  • Larrad Jiménez A. Síndrome hipoglucémico. En: Sitges-Serra A y Sancho Inserser J (eds.): Cirugía Endocrina. Guías Clínicas de la Asociación Española de Cirujanos. Ediciones Arán. Madrid, 1999; 25: 203-13.
  • Hiramoto JS, Vickie A, Feldstein VA, LaBerge JM et al. Intraoperative ultrasound and preoperative localization detects all occult insulinomas. Arch Surg 2001; 136: 1020-6.
  • Ravi K, Britton BJ. Surgical approach to insulinomas: are preoperative localisation tests necessary? Ann R Coll Surg Engl 2007; 89: 212-7.
  • Menzel J, Domschke W. Intraductal ultrasonography may localize islet cell tumours negative on endoscopic ultrasound. Scand J Gastroenterol 1998; 33: 109-12.
  • Lo CY, Chan FL, Tam SC, Fan ST et al. Value of intra-arterial calcium stimulated venous sampling for regionalization of pancreatic insulinomas. Surgery 2000; 128: 903-9
  • Carneiro, DM; Levi, JU; Irvin, GL., Rapid insulin assay for intraoperative confirmation of complete resection of insulinomas. Surgery 2002; 132: 937–42.
  • Strong VE, Shifrin A, Inabnet WB. Rapid intraoperative insulin assay: a novel method to differentiate insulinoma from nesidioblastosis in the pediatric patient. Ann Surg Innov Res. 2007; 1: 6-9.
  • O’Riordain DS, O’Brien T, Van Heerden JA, Service FJ et al. Surgical management of insulinoma associated with multiple endocrine neoplasia type I. World J Surg 1994; 18: 488-93.
  • Liu H, Peng C, Zhang S, Wu Y et al. Strategy for the Surgical Management of Insulinomas: Analysis of 52 Cases. Dig Surg 2007; 24: 463-70.
  • Fernández del Castillo C, Rattner DW, Warshaw AL. Standards for pancreatic resecction in the 1990s. Arch Surg 1995; 130: 295- 300.
  • Lo CY, Lam KY, Kung AW, Lam KS et al. Pancreatic insulinoma: a 15-year experience. Arch Surg 1997; 132: 926-30
  • Lillemoe KD, Kaushal S, Cameron JL, Taylor AS, et al. Distal pancreatectomy: indications and outcomes in 235 patients. Ann Surg 1999; 229: 673-700.
  • Gagner M, Pomp A, Herrera MF. Early experience with laparoscopic resections of islet cell tumors. Surgery 1996; 120:1051-4.
  • Pietrabissa A, Shimi S M, Vander Velpen G, Cuschieri A. Localization of insulinoma by laparoscopic infragastric inspection of the pancreas and contact ultrasonography. Surg Oncol 1993; 2: 83-86.
  • Salky BA, Edye M. Laparoscopic pancreatectomy. Surg Clin North Am 1996; 76: 539-45.
  • Cushieri A, Jakimowicz JJ, van Spreeuwel J. Laparoscopic distal 70% pancreatectomy and splenectomy for chronic pancreatitis. Ann Surg 1996; 223: 280-5.
  • Gramática L, Herrera MF, Mercado-Luna A, Sierra M, et al. Videolaparoscopic resection of insulinoma: experience in two institutions. World J Surg 2000; 26: 1297-300.
  • Berends FJ, Cuesta, Kazemier G, van Eijck C, et al. Laparoscopic detection and resection of insulinomas. Surgery 2000; 128: 386-91.
  • Park AE, Heniford BT. Therapeutic laparoscopy of the pancreas. Ann Surg 2002; 236: 149-58.
  • Fernández-Cruz L, Sáenz A, Astudillo E, Martínez I, et al. Outcome of laparoscopic pancreatic surgery: endocrine and nonendocrine tumors. World J Surg 2002; 26: 1057-65.
  • Jaroszewski DE, Schlinkert RT, Thompson GB, Schlinkert DK. Laparoscopic localization and resection of insulinomas. Arch Surg 2004; 139: 270-4
  • Assalia A, Gagner M. Laparoscopic pancreatic surgery for islet tumors of the pancreas. World J Surg 2004; 28: 1239-47.
  • Mabrut JY, Fernández-Cruz L, Azagra JS, Bassi C, et al. Laparoscopic pancreatic resections: result of a multicenter European study of 127 patients. Surgery 2005; 137: 597-605.
  • Toniato A, Meduri F, Foletto M, Avogaro A, et al. Laparoscopic treatment of benign insulinomas localized in the body and tail of the pancreas: a single-center experience. World J Surg 2006; 30: 1916-9.
  • Sa Cunha A, Beau C, Rault A, et al. Laparoscopic versus open approach for solitary insulinoma. Surg Endosc 2007; 21:103-8.
  • Bassi C, Falconi M, Salvia R, Caldiron E, et al. Role of octreotide in the treatment of external pancreatic pure fistulas: a single institution prospective experience. Langenbecks Arch. Surg. 2000; 385: 10–13.
  • Service FJ, McMahon MM, O’Brien PC, Ballard DJ. Functioning insulinoma: incidence, recurrence and long-term survival of patientes: a 60-years study. Mayo Clin. Proc 1991; 66: 711-9.
  • Simon, D, Starke A, Goretzki PE, Roeher HD. Reoperative surgery for organic hyperinsulinism: indications and operative strategy. World J Surg 1998; 22: 666-72.
  • Kaczirek K, Niederle B. Nesidioblastosis: an old term and a new understanding. World J Surg 2004; 28: 1227-30.
  • Nikfarjam M, Warshaw AL, Axelrod L, Deshpande V, et al. Improved contemporary surgical management of insulinomas: a 25-year experience at the Massachusetts General Hospital. Ann Surg. 2008; 247: 165-72.
  • Sarmiento JM, Que FG, Grant CS, Thompson GB, et al. Concurrent resections of pancreatic islet cell cancers with synchronous hepatic metastases: outcomes of an aggressive approach. Surgery 2002; 132: 976-82.
  • Chamberlain RS, Canes D, Brown KT, Saltz L et al. Hepatic neuroendocrine metastases: does intervention alter outcomes? J Am Coll Surg 2000; 190: 432-445.
  • Norton JA, Kivlen M, Li M, Schneider D et al. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors. Arch Surg 2003; 138(8): 859-66
  • Vauthey JN, Chaoui A, Do KA, Bilimoria MM, et al. Standardized measurement of the future liver remnant prior to extended liver resection: Methodology and clinical associations. Surgery 2000; 127: 512-9.
  • Sarmiento JM, Heywood G, Rubin J, Ilstrup DM, et al. Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival. J Am Coll Surg 2003; 197: 29-37.
  • Bajetta E, Ferrari L, Procopio G, Catena L, et al. Efficacy of a chemotherapy combination for the treatment of metastatic neuroendocrine tumours. Ann Oncol 2002; 13: 614–21.
  • Mavligit GM, Pollock RE, Evans HL,Wallace S. Durable hepatic tumor regression after arterial chemoembolization-infusion in patients with islet cell carcinoma of the pancreas metastatic to the liver. Cancer 1993; 72: 375–80.